D. Reed

发表

Adenovirus-based p53 gene therapy in ovarian cancer.

D. Carbone, J. Mathis, C. Muller, 1995, Gynecologic oncology.

Alteration of glycosylation renders HIV sensitive to inactivation by normal human serum.

X. Lin, R. Rother, D. Reed, 1997, Journal of immunology.

Evaluation of the Galα1-3Gal Epitope as a Host Modification Factor Eliciting Natural Humoral Immunity to Enveloped Viruses

R. Welsh, R. Rother, D. Reed, 1998, Journal of Virology.

Primary Structure and Functional Characterization of a Soluble, Alternatively Spliced Form of B7-11

L. Matis, W. Fodor, R. Rother, 2000, The Journal of Immunology.

Primary Structure and Functional Characterization of a Soluble, Alternatively Spliced Form of B7-1

L. Matis, W. Fodor, R. Rother, 2000 .

Spliced Form of B7-1 Characterization of a Soluble, Alternatively Primary Structure and Functional

L. Matis, W. Fodor, R. Rother, 2000 .

Characterization of the growth inhibition induced by tumor-promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cells.

A. Gescher, D. Reed, 1985, Cancer research.

Tumor‐Associated Macrophages Share In Vitro Growth Characteristics With Resident but not Elicited Macrophages

K. Burnham, D. Reed, Doug Reed, 1991, Journal of leukocyte biology.

Role of differential mRNA stability in the regulated expression of IgM and IgD.

T. Dang, D. Yuan, D. Reed, 1994, Journal of immunology.

Recombinant human tumor necrosis factor increases granulocyte cell-surface complement receptor number.

F. Moore, D. Reed, 1988, Archives of Surgery.